-
ADAP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Adaptimmune Therapeutics (ADAP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 119.42 mm | 119.42 mm | 119.42 mm | 119.42 mm | 119.42 mm | 119.42 mm |
Cash burn (monthly) | 31.75 mm | (no burn) | 5.60 mm | 3.60 mm | 18.15 mm | 9.52 mm |
Cash used (since last report) | 127.70 mm | n/a | 22.50 mm | 14.49 mm | 73.00 mm | 38.30 mm |
Cash remaining | -8.28 mm | n/a | 96.92 mm | 104.93 mm | 46.42 mm | 81.12 mm |
Runway (months of cash) | -0.3 | n/a | 17.3 | 29.1 | 2.6 | 8.5 |
13F holders | Current |
---|---|
Total holders | 80 |
Opened positions | 16 |
Closed positions | 13 |
Increased positions | 21 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 143.93 bn |
Total shares | 254.12 mm |
Total puts | 5.80 k |
Total calls | 60.80 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
New Enterprise Associates 14 | 102.48 mm | $150.64 mm |
Matrix Capital Management | 37.68 mm | $35.81 bn |
EcoR1 Capital | 27.40 mm | $26.04 bn |
NEA Management | 17.08 mm | $16.23 bn |
Baillie Gifford & Co | 16.78 mm | $15.94 bn |
Long Focus Capital Management | 13.30 mm | $12.64 bn |
Partner Fund Management | 10.00 mm | $9.50 bn |
MPM Asset Management | 5.56 mm | $5.28 bn |
MPM Oncology Impact Management | 5.10 mm | $4.84 bn |
BAC Bank of America | 4.65 mm | $4.42 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Adrian Rawcliffe | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.5808 | 30,601 | 17.77 k | 44,327 |
17 Jan 25 | Elliot Norry | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.5808 | 5,584 | 3.24 k | 7,510 |
17 Jan 25 | John Lunger | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.5808 | 5,584 | 3.24 k | 7,510 |
17 Jan 25 | Bertrand William C JR | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.5808 | 5,584 | 3.24 k | 7,510 |
15 Jan 25 | Cintia Piccina | American Depositary Shares representing Ordinary Shares | Sell | Dispose S | No | No | 0.5748 | 12,991 | 7.47 k | 18,421 |